StageZero Life Sciences
€0.02
18
+€0+0% Monday 06:00
Statistik
Harga Tertinggi Hari Ini
-
Harga Terendah Hari Ini
-
52M Tinggi
-
52M Rendah
-
Volume
-
Rata-Rata Volume
-
Kap Pasar
3.36M
Rasio P/E
-
Hasil Dividen
-
Dividen
-
Mendatang
Pendapatan
12NovDiharapkan
EPS yang Diharapkan
T/A
EPS Aktual
T/A
Orang Juga Mengikuti
Daftar ini didasarkan pada daftar pantauan orang-orang di Stock Events yang mengikuti 61N1.F. Ini bukan rekomendasi investasi.
Peserta
Daftar ini adalah analisis berdasarkan peristiwa pasar terbaru. Ini bukan rekomendasi investasi.
Guardant Health
GH
Kap Pasar3.15B
Exact Sciences
EXAS
Kap Pasar11.4B
Fulgent Genetics
FLGT
Kap Pasar683.49M
Bionano Genomics
BNGO
Kap Pasar42.14M
Pacific Biosciences of California
PACB
Kap Pasar373.36M
Illumina
ILMN
Kap Pasar20.93B
Qiagen NV
QGEN
Kap Pasar10.16B
Thermo Fisher Scientific
TMO
Kap Pasar234.95B
Quest Diagnostics
DGX
Kap Pasar17.47B
Tentang
StageZero Life Sciences Ltd., a vertically integrated healthcare company, develops and commercializes proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications in North America and Western Europe. Its proprietary platform technology is Sentinel Principle, which identifies RNA-based biomarkers from whole blood. The company's lead product is Aristotle, a mRNA-based multi-cancer panel test for for the detection of multiple discrete cancers from a single sample of blood. It also offers ColonSentry, a blood test to determine an individual's current risk for having colorectal cancer; Prostate Health Index, a screening test for prostate cancer; BreastSentry, a test to determine a woman's risk for developing breast cancer; and COVID-19 Tests. The company is based in Richmond Hill, Canada.
Show more...
CEO
Mr. James R. Howard-Tripp
Karyawan
40
Negara
CA
ISIN
CA8525403017
WKN
000A2QES5